Daily news
Daily news for TNPSC and other Tamil Nadu exams — short, exam-focused, in Tamil and English.
The World Health Organization (WHO) has granted prequalification to CERVAVAC, the first quadrivalent Human Papillomavirus (HPV) vaccine made in India to earn this status. A quadrivalent vaccine protects against four type...
The Union Ministry of Health and Family Welfare has advised States and Union Territories to regulate stem cell therapy. It may be offered as standard care only for Ministry-approved diseases, such as certain blood cancer...
Indian scientists from the Institute of Advanced Study in Science and Technology (IASST) and IIT-Guwahati have created RK-251, a “smart” anticancer drug meant to switch on mainly inside cancer cells, which could reduce h...
IntroductionIn a groundbreaking advancement for precision oncology, Indian researchers from the S. N. Bose National Centre for Basic Sciences (SNBNCBS), Kolkata, and Ashoka University announced on 15 August 2026 the deve...
The International Agency for Research on Cancer (IARC), the WHO's cancer research agency, classified three widely used medicines as "carcinogenic to humans" (Group 1): Hydrochlorothiazide (blood pressure), Voriconazole (...
IntroductionIn a deeply structural and highly massive public health campaign, India is strictly and officially strengthening its forceful efforts to aggressively eliminate viral hepatitis as a public health threat by 203...
The U.S. Food and Drug Administration (FDA) has approved vepdegestrant, the world's first therapy built on PROTAC (Proteolysis-Targeting Chimera) technology.Vepdegestrant is an oral drug developed by Arvinas and Pfizer.I...
IntroductionIn a deeply structural and highly massive technological leap for India's strategic massive medical infrastructure, the Maharashtra Cabinet strictly and officially approved the massive High-Energy Medical Cycl...
India has approved Pluvicto, the first radioligand therapy (RLT) in the country for treating advanced prostate cancer. Radioligand therapy is a form of targeted nuclear medicine in which a radioactive substance is attach...
India has validated Truenat HR-HPV-Plus, the country's first indigenously developed screening test for Human Papillomavirus (HPV), the main cause of cervical cancer. The test was developed by Molbio Diagnostics. It is al...
Public Health Advocacy: WHO Mobilizes Anti-Nicotine Frameworks to Counter E-Cigarette Targeting in Modern ClassroomsMarked across the international public health calendar to expand health awareness and counter the aggres...
Two notable medical launches have taken place in India. Donanemab, sold under the brand name Lormalzi, has been introduced as the country’s first disease-modifying therapy for Alzheimer’s disease, a treatment that target...
